Search

BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.

… Friday, July 17, 2020 Summary Scientists at Memorial Sloan Kettering have found that BCG, a commonly used immunotherapy for bladder cancer , works differently than many researchers had assumed. For people with early-stage bladder cancer, an immunotherapy called BCG has been the standard treatment for

… Friday, September 30, 2022 The idea came to Swathi Iyer on the subway, while headed to a Broadway show: The best way to explain brain cancer’s need for cholesterol is to liken it to an addiction. And the processes that regulate cholesterol activity present in normal brain cells are like the local police

Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label.

… Friday, January 17, 2014 Summary Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label. Many people search the web, ask friends and family, or look in reference books when they want to know if an herb

Two brothers discuss their surprise at being diagnosed with Lynch syndrome.

… Thursday, July 19, 2018 Summary One man’s cancer diagnosis spurs his brother to undergo more frequent cancer screenings, a decision that may have saved his life. When his younger brother, Mitchell, was found to have urothelial cancer in 2011, Elliot Katz never expected that diagnosis might save his own

Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine. Dr. Diaz formally assumes the role as David Spriggs, MD, steps down after nearly 13 years.

… Monday, April 17, 2017 Luis A. Diaz, MD , has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new longitudinal study from researchers at Memorial Sloan Kettering Cancer Center finds that while clinicians' and patients' reporting of treatment side effects are very different from each other, together they provide a more complete, clinically meaningful picture of the treatment experience.

… Monday, November 16, 2009 In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information. A new

For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.

… Wednesday, January 1, 2020 Middle school chorus and orchestra teacher Melissa Crouse had lived in the Pittsburgh area her whole life. But on a trip to visit her brother in southwest Florida, she decided on a whim to apply for teaching jobs there. The single mom, then 51, quickly received an offer. “Three

A five-year grant of more than $1.4 million will fund a program to train nurses in helping survivors achieve the best possible quality of life after cancer.

… Monday, October 17, 2011 A five-year grant worth more than $1.4 million from the National Cancer Institute will enable City of Hope and Memorial Sloan Kettering Cancer Center to train nurses working with cancer survivors who are transitioning from active treatment to survivorship care. Nearly 12 million

Read about the latest MSK research to make CAR T therapy effective against solid tumors.

… Tuesday, September 3, 2024 When Marylou Barton heard her biopsy results, she held her daughter Kristin’s hand while they both sobbed in the doctor’s office. The mesothelioma — a rare and aggressive cancer that arose in the lining of Marylou’s lungs — appeared to have spread. She likely had about a year

New MSK research finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.

… Friday, March 27, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system